On December 1, 2021 Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, reported it will host a virtual Investor Day on Wednesday, December 8, 2021 from 10:00 a.m. to 12:30 p.m. ET (Press release, Karyopharm, DEC 1, 2021, View Source,-2021 [SID1234596382]). Karyopharm’s executive management team will be joined by six recognized thought leaders in multiple myeloma, gynecological malignancies, myelodysplastic syndromes and myelofibrosis, including:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Rafael Fonseca, MD, Mayo Clinic
Cristina Gasparetto, MD, Duke University Medical Center
Vicky Makker, MD, Memorial Sloan Kettering Cancer Center
Robert Coleman, MD, US Oncology Research
Guillermo Garcia-Manero, MD, MD Anderson Cancer Center
Srinivas Tantravahi, MBBS, MRCP, University of Utah
The virtual event will outline the Company’s commercial opportunities, refined corporate vision, pipeline priorities and corporate milestones that will support Karyopharm’s continued evolution toward a sustainable, fully-integrated development and commercialization organization.
To access the event, please dial (833) 989-2978 (local) or (236) 714-4042 (international) at least 10 minutes prior to the start time and ask to be joined into the Karyopharm Therapeutics call. A live video webcast of the event will be available under "Events & Presentations" in the Investor section of the Company’s website, View Source An archived webcast will be available on the Company’s website approximately two hours after the event.